ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 45 filers reported holding ATRECA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,900 | -14.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2023 | $5,700 | -94.9% | 5,000 | -85.9% | 0.00% | – |
| Q1 2022 | $112,000 | +33.3% | 35,345 | +27.8% | 0.00% | – |
| Q4 2021 | $84,000 | -60.6% | 27,663 | -19.1% | 0.00% | – |
| Q3 2021 | $213,000 | -37.7% | 34,211 | -14.7% | 0.00% | – |
| Q2 2021 | $342,000 | +521.8% | 40,130 | +1028.2% | 0.00% | – |
| Q1 2021 | $55,000 | – | 3,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,396,644 | $23,000,000 | 5.25% |
| EcoR1 Capital, LLC | 2,426,685 | $39,191,000 | 2.11% |
| Boxer Capital, LLC | 2,202,333 | $35,568,000 | 1.14% |
| Aisling Capital Management LP | 387,653 | $6,261,000 | 1.08% |
| CM Management, LLC | 60,000 | $969,000 | 0.90% |
| Samsara BioCapital, LLC | 474,943 | $7,670,000 | 0.77% |
| Parkman Healthcare Partners LLC | 126,258 | $2,039,000 | 0.52% |
| Redmile Group, LLC | 2,476,068 | $39,988,000 | 0.48% |
| Sio Capital Management, LLC | 128,455 | $2,075,000 | 0.42% |
| HighVista Strategies LLC | 30,824 | $498,000 | 0.32% |